Investigational Drugs List
Groups Distribution
Phase Distribution
Filter Conditions
Investigational Drugs List
| Drugs ID | CID | Drugs | Identifier | Molecular Formula | Molecular Weight | Groups | US Approved | Details |
|---|---|---|---|---|---|---|---|---|
| Drug141 | 54670067 | Ascorbic acid | NCT04457934, NCT05726097, NCT01929668, NCT03581149 | C6H8O6 | 176.12 | approved|nutraceutical | YES | Details |
| Drug142 | 54671203 | Doxycycline | NCT00355602, NCT02606032, NCT03546868 | C22H24N2O8 | 444.40 | approved|investigational | YES | Details |
| Drug143 | 54675783 | Minocycline | NCT06201793 | C23H27N3O7 | 457.50 | approved|investigational | YES | Details |
| Drug144 | 54678486 | Warfarin | NCT03035058, NCT02862132, NCT02712866, NCT05702879, NCT02743806, NCT06850727, NCT04919252, NCT06691061, NCT05481619, NCT06880744, NCT06095596, NCT05205603, NCT03802214, NCT02039505, NCT03138655, NCT06626165, NCT03824561, NCT06095128, NCT04779307, NCT06609 | C19H16O4 | 308.30 | approved | YES | Details |
| Drug145 | 56841910 | Lactated Ringers | NCT00467922 | C3H9CaCl2KNa2O6 | 337.16 | NULL | NULL | Details |
| Drug146 | 57520598 | GLPG0974 | NCT01829321 | C25H25ClN2O4S | 485.00 | NULL | NULL | Details |
| Drug147 | 57928403 | Peficitinib | NCT01959282 | C18H22N4O2 | 326.40 | NULL | NULL | Details |
| Drug148 | 58557659 | Upadacitinib | NCT06780683, NCT06274996, NCT05782907, NCT06095596, NCT03653026, NCT02819635, NCT03345836, NCT05867329 | C17H19F3N6O | 380.40 | NULL | YES | Details |
| Drug149 | 67008033 | GED-0507-34-Levo | NCT02808390 | C10H13NO3 | 195.21 | NULL | NULL | Details |
| Drug150 | 67418070 | MT-1303 | NCT01666327, NCT04857112 | C19H31ClF3NO3 | 413.90 | NULL | NULL | Details |